Undiagnosed neurocutaneous disorders

Gene: DSTYK

Red List (low evidence)

DSTYK (dual serine/threonine and tyrosine protein kinase)
EnsemblGeneIds (GRCh38): ENSG00000133059
EnsemblGeneIds (GRCh37): ENSG00000133059
OMIM: 612666, Gene2Phenotype
DSTYK is in 13 panels

1 review

Rebecca Foulger (Genomics England curator)

Added 'Founder effect' tag based on haplotype analysis in Lee et al. (2017, PMID:28157540) which indicates a founder effect- the same deletion/insertion was identified in 3 unrelated families. At the time of curation, PMID:28157540 provides all evidence for the disease:gene association.
Created: 11 May 2017, 9:53 a.m.
In affected members of 3 unrelated families of Middle Eastern descent with spastic paraplegia-23 (MIM:270750, also called 'Spastic paraplegia with pigmentary abnormalities), Lee et al. (2017, PMID:28157540) identified a homozygous intragenic deletion/insertion in the DSTYK gene. The deletion segregated with the disorder in all 3 families. Haplotype analysis indicated a founder effect. The deletion insertion consisted of a 4-kb deletion associated with a 20-bp insertion, resulting in the removal of the last 2 exons of DSTYK (exons 12 and 13) along with part of the 3-prime untranslated region.
Created: 11 May 2017, 9:52 a.m.

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Other
Phenotypes
  • Spastic paraplegia 23, 270750
  • Disordered pigmentation, spastic paraparesis and peripheral neuropathy
  • SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES
Tags
founder-effect
OMIM
612666
Clinvar variants
Variants in DSTYK
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

11 May 2017, Gel status: 0

Added New Source

Rebecca Foulger (Genomics England curator)

DSTYK was added to Undiagnosed neurocutaneous disorderspanel. Sources: Other

11 May 2017, Gel status: 0

Created

Rebecca Foulger (Genomics England curator)

DSTYK was created by rfoulger